PATENT CLAIM ANALYSIS

Application Number: 15957474
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["424", "400000"]

Abstract:
Described herein are drug delivery systems for delivering biologically active agents comprising primary or secondary amines, or a ring nitrogen atom of an azaheteroaryl ring, pharmaceutically acceptable salts thereof, drug delivery reagents related thereto, pharmaceutical compositions comprising the drug delivery systems, and the use of the drug delivery systems as sustained release therapeutics.

Claim (Index 87):
A method for treating a disease or disorder, comprising administering to a subject in need thereof the drug delivery system or pharmaceutically acceptable salt thereof according to  claim 69 ,\n wherein the disorder is macular degeneration and D is a biologically active moiety comprising at least one primary or secondary amine or a ring nitrogen atom of an azaheteroaryl ring comprising D2 (SEQ ID NO:4), D3 (SEQ ID NO:5), other insulin like growth factors, or a combination thereof; or the disorder is cardiac disorders and D is a biologically active moiety comprising at least one primary or secondary amine or a ring nitrogen atom of an azaheteroaryl ring comprising serelaxin or SEQ ID NO:7;

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 1.43902
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11150522', '13397195', '14849270', '14512059', '13984762']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6972745983589264
- 35 USC 102 Novelty (BERT): 0.5193192071366891
- Combined Prediction Score: 0.6794790592367027
- Mean Citation Score: 264.81159
- Max Citation Score: 277.69498
- Similarity Product: 178.46473639264943

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test